Skip to main content
. 2007 Dec;9(12):1046–1056. doi: 10.1593/neo.07682

Table 3.

Percent enhancement measured after the injection of Gd-AAZTAC17 and Gd-AAZTAC17/LDL adduct.

Tissue 4 hours (%) 24 hours (%) 48 hours (%)



Gd-AAZTAC17 Gd-AAZTAC17/LDL Gd-AAZTAC17 Gd-AAZTAC17/LDL Gd-AAZTAC17 Gd-AAZTAC17/LDL
Liver 207 ± 27 280 ± 23 78 ± 16 84 ± 15 37 ± 14 23 ± 7
Tumor 22 ± 5 42 ± 9 5 ± 3 13 ± 4 4 ± 1 10 ± 1